Trevi Therapeutics (TRVI) Long-Term Debt Repayments (2018 - 2023)
Trevi Therapeutics (TRVI) posted quarterly Long-Term Debt Repayments of $7.7 million for Q2 2023, up 337.66% year-over-year from $1.8 million in Q2 2022, and up 337.66% quarter-over-quarter from $1.8 million in Q1 2023.
Powered by 
Analysis
Trevi Therapeutics (TRVI) Long-Term Debt Repayments (2018 - 2023) Analysis & Trends
Trevi Therapeutics' Long-Term Debt Repayments history runs 3 years deep, the most recent figure standing at $7.7 million for Q2 2023.
- In Q2 2023, Long-Term Debt Repayments rose 337.66% year-over-year to $7.7 million; the TTM figure through Sep 2023 stood at $11.2 million (up 173.3% YoY), while the FY2022 annual figure was $5.8 million, changed N/A from the prior year.
- Long-Term Debt Repayments for Q2 2023 stood at $7.7 million, up from $1.8 million in the prior quarter.
- The five-year high for Long-Term Debt Repayments was $7.7 million in Q2 2023, with the low at $583000.0 in Q1 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 17.05 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Trevi Therapeutics | 2.71 Bn | 2.71 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 7.66 Mn |
| Mar 31, 2023 | 1.75 Mn |
| Dec 31, 2022 | 1.75 Mn |
| Sep 30, 2022 | 1.75 Mn |
| Jun 30, 2022 | 1.75 Mn |
| Mar 31, 2022 | 583,000.00 |
| Sep 30, 2018 | 1,000.00 |
| Jun 30, 2018 | 2.75 Mn |
| Mar 31, 2018 | 2.06 Mn |